Market Research Report
Global Tumor Ablation Market 2015-2019
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||348242|
|Published||Content info||70 Pages
Delivery time: 1-2 business days
|Global Tumor Ablation Market 2015-2019|
|Published: December 30, 2015||Content info: 70 Pages||
Tumor ablation is a minimally invasive, image-guided treatment procedure that is used to destroy cancer cells in the chest, lung, and liver. Recent advances in semiconductor technology and modifications to the design of medical laser systems such as MRI or ultrasound are responsible for this markets healthy growth rate of more than 15% during the forecast period.
Geographically, the EMEA region is expected to account for the highest market share during the forecast period. The growing prevalence of cancer in countries such as Denmark, Belgium, France, and Norway is responsible for this regions high market share of close to 37% by 2019.
In this market research report, Technavio analysts estimate the radiofrequency segment to account for approximately 13% of the total market share by 2019. Radiofrequency is very specific for treating target tissues without causing significant damage to surrounding healthy cells. The high efficacy rate of this procedure is expected to bolster its growth during the forecast period.
Technavios analyst has estimated the liver cancer segment to account for the highest market share during the forecast period. Liver cancer is more common in men than in women and is characterized by uncontrolled cell division in the liver. High incidence of primary liver cancer and bile duct cancer among the populace will result in this segments high market dominion during the forecast period.
This market offers ample growth opportunities to vendors during the forecast period and is characterized by the presence of numerous local and multinational vendors. While the international players are continually increasing their footprint in the market through product innovations, local vendors adopt collaborations to stay competitive in the market.
Leading vendors in this market are-
Other prominent vendors are Alpinion Medical System, BSD Medical, Conmed, C2 Therapeutics, CSA Medical, C.R. Bard, Chongqing Haifu Medical Technology, Esaote, EDAP TMS, Galil Medical, InSightec, Misonix, Mermaid Medical, Monteris Medical, Neuwave Medical, Olympus, Perseon, Plasma Surgical, Profound Medical, Philips Healthcare, Smith & Nephews, Sonacare Medical, Shenzhen Huikang Medical Apparatus, Terumo Medical, Total Vein Systems, Theraclion, and Vivant Medical.